During the past decade, Praxis für Innere Medizin, Dr.Oettle Helmut conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Praxis für Innere Medizin, Dr.Oettle Helmut" are "Antimetabolites, Antineoplastic" (1 trials), "Digestive System Diseases" (1 trials), "Digestive System Neoplasms" (1 trials), "Endocrine Gland Neoplasms" (1 trials) and "Endocrine System Diseases" (1 trials). Many other conditions were trialed in "Praxis für Innere Medizin, Dr.Oettle Helmut" in a lesser frequency.

Most popular intervention types in "Praxis für Innere Medizin, Dr.Oettle Helmut" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (2 trials), "Albumin-bound paclitaxel (ABI-007)" (1 trials) and "nab-Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Praxis für Innere Medizin, Dr.Oettle Helmut" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Praxis für Innere Medizin, Dr.Oettle Helmut". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Praxis für Innere Medizin, Dr.Oettle Helmut, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxis für Innere Medizin, Dr.Oettle Helmut, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".